There are no cohort studies describing outcomes of patients colonized with vancomycin-resistant enterococci (VRE) undergoing allogeneic hematopoietic stem cell transplantation (AHSCT). We therefore ...

Antimicrobials with the potential to act as immune stimulators and overcome bacterial resistance are emerging as important alternative approaches to fighting antimicrobial resistance The novel ...

SER-155 is an oral live biotherapeutic being investigated to treat disruptive conditions of the gastrointestinal tract. In a ...

Vancomycin-resistant enterococcal bloodstream infections (VRE-BSI) are life-threatening and notoriously difficult to treat. While both linezolid and daptomycin are used, studies show no clear ...

V-161 targets a crucial enzyme in VRE, offering promise in combating antibiotic-resistant infections in hospital environments A major finding of this study was the high-resolution structural analysis ...

C. difficile infection recurrence rates were numerically lower with vancomycin than with placebo, though the difference was not significant. However, the results could be clinically meaningful, an ...

Purpose. The feasibility of using a limitedsampling algorithm for administration of vancomycin for treatment of vascular-access-related bacteremia in outpatient high flux hemodialysis was investigated ...